摘要
目的:调查全身麻醉苏醒期躁动的发生率并分析其可能原因。方法:全身麻醉下行外科手术的患者1 600例,手术结束后在麻醉恢复室采用Riker镇静、躁动评分(Sedation-Agitation Scale,SAS)进行躁动诊断,调查躁动的发生率。结果:1 600例患者中出现苏醒期躁动有114例(7.1%),其中糖尿病史患者有15例(13.2%),麻醉诱导后导尿患者86例(75.4%),乳腺手术患者19例(16.7%),腹部手术患者35例(30.7%),泌尿外科手术患者25例(21.9%),七氟烷麻醉患者54例(47.4%)。苏醒期躁动与糖尿病史、麻醉诱导后导尿、手术时间、乳腺手术、腹部手术、泌尿外科手术及七氟烷麻醉相关;与年龄、性别、体质量、ASA分级、高血压病史及既往手术史无关。结论:糖尿病史、麻醉诱导后导尿、手术时间、乳腺手术、腹部手术、泌尿外科手术及七氟烷麻醉是全身麻醉苏醒期躁动的主要危险因素。
Objective To investigate the incidence and risk factors of emergence agitation during recovery from general anaesthesia in patients after surgery.Methods A total of 1 600 patients who underwent surgery with general anaesthesia were enrolled for this study.Patients were interviewed in the post-anaesthesia care unit(PACU) to determine the occurrence of agitation according to the Riker sedation-agitated scale.Results Of all the patients,114(4.7%) patients developed agitation in the PACU.Among them,15(13.2%) were diabetes,86(75.4%) were urethral catheterization after anesthesia induction,19(16.7%) underwent breast surgery,35(30.7%) underwent abdominal surgery,5(21.9%) underwent urological surgery,and 54(47.4%) received sevoflurane anesthesia and long duration of surgery increased the risk of agitation.Logistic regression analysis showed that emergence agitation was positively correlated with diabetes,urethral catheterization after anesthesia induction,the breast,abdominal,and urological surgery,the duration of surgery and sevoflurane maintenance.age,sex,body weight,ASA physical status and history of hypertension and pre-surgery did not affect the incidence of emergence agitation.Conclusion Diabetes,urethral catheterization after anesthesia induction,breast,abdominal,and urological surgery,duration of surgery,and sevoflurane maintenance are risk factors for emergence agitation.
出处
《国际病理科学与临床杂志》
CAS
2010年第3期196-200,共5页
Journal of International Pathology and Clinical Medicine
关键词
躁动
全身麻醉
恢复期
麻醉
糖尿病
留置导尿管
手术
七氟烷
agitation
general anesthesia
recovery period
anesthesia
diabetes
indwelling urinary catheterization
surgery
sevoflurane